Arrowhead Pharmaceuticals (ARWR) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Arrowhead Pharmaceuticals · Health Care · ref. ETF XLV · 91 calls · price $88.59
What the company does: Arrowhead Pharmaceuticals, Inc., founded in 1989 and based in Pasadena, California, is a biopharmaceutical company dedicated to discovering and advancing innovative treatments for complex and challenging-to-treat diseases within the United States.
📈 Arrowhead Pharmaceuticals (ARWR) stock price
$88.59+296.6% over range
Aug 28, 25low $22.03 · high $89.59Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
80% recommend buying · 10 analysts
📊 JPI status : Arrowhead Pharmaceuticals is no longer in our current JPI rankings, but appeared in the past (2025, 2015) — its upside may be behind it. See the stocks picked in 2025 →
🎯 ARWR price target & analyst consensus — price $88.59
The price target · all analysts combined (10 targets)
Highest target · 1 firm of 10$126+42.2%
Median target · of 10 targets$106.5+20.2%
Lowest target · 1 firm of 10$46-48.1%
Current price$88.59
Where these 10 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
770%
$95 ↔ $126
Below
330%
$46 ↔ $87
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: HC Wainwright & Co. — 70% of its targets hit on this sector (238 calls tested). It aims for $120 (+36 %), call made on August 7, 2026, maturing on August 7, 2027 (21 d ago).
The 3 reliable analysts
$115+30 %
The 7 other firms
$95+7.2 %
How to read it: the 3 reliable firms are not filtered by optimism — 3 aim above the price, 0 below, hence their $115 median. “The 7 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 10 ratings (last 6 months)
Strong Buy00%
Buy880%
Hold220%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 ARWR price target all
All 91 calls, one by one, with our verdict on each firm.
→ See all 91 targets, analyst by analyst💡 The best analysts on ARWR most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in ARWR? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Arrowhead Pharmaceuticals? The JPI assistant answers using our backtest data.
📈 Arrowhead Pharmaceuticals fundamentals: valuation, margins & growth › open the full page
P/E —Net margin -47.8 %Revenue growth +171.0 %Not (yet) profitable
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. -72 %
2023
Rev −1%
2024
Rev −99%
2025
Rev +23258%
🔎 Detailed analyses
✅ Historical analyst reliability on ARWR
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Baird ↗ | 75% | +21.3% | 4 |
| Cantor Fitzgerald ↗ | 62% | +73.5% | 8 |
| B. Riley Securities ↗ | 50% | +42.0% | 10 |
| Piper Sandler ↗ | 50% | +38.0% | 10 |
| B of A Securities ↗ | 50% | -17.0% | 2 |
| HC Wainwright & Co. ↗ | 46% | +57.1% | 24 |
| Chardan Capital | 42% | +59.7% | 19 |
| RBC Capital ↗ | 42% | +47.0% | 12 |
| Jefferies ↗ | 33% | +29.9% | 3 |
| Goldman Sachs ↗ | 25% | -28.3% | 4 |
📊 What $1,000 invested in Arrowhead Pharmaceuticals would be worth › open the full page
In short — $1,000 invested in Arrowhead Pharmaceuticals 10 years ago would be worth $13,254 today, i.e. +29%/yr on average. Best year: 2019 (+411%), worst: 2016 (-75%). Price performance, excluding dividends.
If I'd invested $1,000 in Arrowhead Pharmaceuticals
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $4,336 | +334% |
| 3 years ago | $2,010 | +101% |
| 5 years ago | $1,062 | +6% |
Return by year (Arrowhead Pharmaceuticals)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +23% | $1,228 (+23%) |
| 2025 | +253% | $4,336 (+334%) |
| 2024 | -39% | $2,664 (+166%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Arrowhead Pharmaceuticals
Loading news…
📋 All analyst calls on ARWR
Filtered on — · ✕ show all
HC Wainwright & Co. ↗
Aug 6, 26
▲ Buy · 🎯$120
Price at call : $87.65 — upside +37%
Today : $88.59 — upside +35%
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
B. Riley Securities ↗
Jul 30, 26
▲ Buy · 🎯$123
Price at call : $84.65 — upside +45%
Today : $88.59 — upside +39%
🎯 on ARWR : 50% (10 calls matureds) · 📊 on Health : 47.8% · +20.1% (23 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
HC Wainwright & Co. ↗
Jul 27, 26
▲ Buy · 🎯$115
Price at call : $85.53 — upside +34%
Today : $88.59 — upside +30%
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
in progress (365j)
matures : Jul 27, 27
matures : Jul 27, 27
Morgan Stanley ↗
Jul 23, 26
▲ Overweight · 🎯$120
Price at call : $85.6 — upside +40%
Today : $88.59 — upside +35%
🎯 on ARWR : no call matured yet · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Jul 23, 27
matures : Jul 23, 27
Piper Sandler ↗
Jul 23, 26
▲ Overweight · 🎯$126
Price at call : $85.6 — upside +47%
Today : $88.59 — upside +42%
🎯 on ARWR : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Jul 23, 27
matures : Jul 23, 27
Chardan Capital
Jul 22, 26
▲ Buy · 🎯$115
Price at call : $86.78 — upside +33%
Today : $88.59 — upside +30%
🎯 on ARWR : 42% (19 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
in progress (365j)
matures : Jul 22, 27
matures : Jul 22, 27
▲ Overweight · 🎯$95
Price at call : $71.65 — upside +33%
Today : $88.59 — upside +7%
🎯 on ARWR : no call matured yet · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : Jul 17, 27
matures : Jul 17, 27
▲ Buy · 🎯$98
Price at call : $71.91 — upside +36%
Today : $88.59 — upside +11%
🎯 on ARWR : no call matured yet · 📊 on Health : 48% · +12.4% (98 calls)
in progress (365j)
matures : Jul 14, 27
matures : Jul 14, 27
See the other 83 calls, newest to oldest
HC Wainwright & Co. ↗
Jul 1, 26
▲ Buy · 🎯$100
Price at call : $83.99 — upside +19%
Today : $88.59 — upside +13%
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
in progress (365j)
matures : Jul 1, 27
matures : Jul 1, 27
Chardan Capital
Jun 30, 26
▲ Buy · 🎯$90
Price at call : $81.51 — upside +10%
Today : $88.59 — upside +2%
🎯 on ARWR : 42% (19 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
in progress (365j)
matures : Jun 30, 27
matures : Jun 30, 27
Leerink Partners ↗
Jun 17, 26
■ Market Perform neutral · not a buy · 🎯$72
Price at call : $81.82 — gap to target -12%
Today : $88.59 — gap to target -19%
🎯 on ARWR : no call matured yet · 📊 on Health : 54.5% · +10.0% (11 calls)
in progress (365j)
matures : Jun 17, 27
matures : Jun 17, 27
■ Market Perform neutral · not a buy · 🎯$46
Price at call : $79.69 — gap to target -42%
Today : $88.59 — gap to target -48%
🎯 on ARWR : no call matured yet · 📊 on Health : 50% · -5.0% (6 calls)
in progress (365j)
matures : May 13, 27
matures : May 13, 27
RBC Capital ↗
May 8, 26
▲ Outperform · 🎯$87
Price at call : $77.74 — upside +12%
Today : $88.59 — upside -2%
🎯 on ARWR : 100% (2 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
in progress (365j)
matures : May 8, 27
matures : May 8, 27
▲ Overweight · 🎯$88
Price at call : $74.81 — upside +18%
Today : $88.59 — upside -1%
🎯 on ARWR : no call matured yet · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : May 1, 27
matures : May 1, 27
Morgan Stanley ↗
Apr 21, 26
▲ Overweight · 🎯$100
Price at call : $71.05 — upside +41%
Today : $88.59 — upside +13%
🎯 on ARWR : no call matured yet · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Apr 21, 27
matures : Apr 21, 27
HC Wainwright & Co. ↗
Mar 25, 26
▲ Buy · 🎯$100
Price at call : $60.77 — upside +65%
Today : $88.59 — upside +13%
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
in progress (365j)
matures : Mar 25, 27
matures : Mar 25, 27
HC Wainwright & Co. ↗
Feb 10, 26
▲ Buy · 🎯$100
Price at call : $62.92 — upside +59%
Today : $88.59 — upside +13%
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
in progress (365j)
matures : Feb 10, 27
matures : Feb 10, 27
B. Riley Securities ↗
Jan 22, 26
▲ Buy · 🎯$101
Price at call : $69.59 — upside +45%
Today : $88.59 — upside +14%
🎯 on ARWR : 50% (10 calls matureds) · 📊 on Health : 47.8% · +20.1% (23 calls)
in progress (365j)
matures : Jan 22, 27
matures : Jan 22, 27
HC Wainwright & Co. ↗
Jan 21, 26
▲ Buy · 🎯$100
Price at call : $69.59 — upside +44%
Today : $88.59 — upside +13%
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
in progress (365j)
matures : Jan 21, 27
matures : Jan 21, 27
Piper Sandler ↗
Jan 13, 26
▲ Overweight · 🎯$110
Price at call : $65.91 — upside +67%
Today : $88.59 — upside +24%
🎯 on ARWR : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Jan 13, 27
matures : Jan 13, 27
Goldman Sachs ↗
Jan 7, 26
■ Neutral neutral · not a buy · 🎯$85
Price at call : $65 — gap to target +31%
Today : $88.59 — gap to target -4%
🎯 on ARWR : no call matured yet · 📊 on Health : 57.9% · +13.8% (107 calls)
in progress (365j)
matures : Jan 7, 27
matures : Jan 7, 27
Morgan Stanley ↗
Jan 7, 26
■ Equal-Weight neutral · not a buy · 🎯$81
Price at call : $65 — gap to target +25%
Today : $88.59 — gap to target -9%
🎯 on ARWR : no call matured yet · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Jan 7, 27
matures : Jan 7, 27
Chardan Capital
Jan 7, 26
▲ Buy · 🎯$80
Price at call : $65.69 — upside +22%
Today : $88.59 — upside -10%
🎯 on ARWR : 42% (19 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
in progress (365j)
matures : Jan 7, 27
matures : Jan 7, 27
Piper Sandler ↗
Dec 17, 25
▲ Overweight · 🎯$100
Price at call : $64.8 — upside +54%
Today : $88.59 — upside +13%
🎯 on ARWR : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Dec 17, 26
matures : Dec 17, 26
RBC Capital ↗
Dec 11, 25
▲ Outperform · 🎯$80
Price at call : $70.09 — upside +14%
Today : $88.59 — upside -10%
🎯 on ARWR : 100% (2 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
in progress (365j)
matures : Dec 11, 26
matures : Dec 11, 26
B of A Securities ↗
Dec 9, 25
▲ Buy · 🎯$81
Price at call : $68.87 — upside +18%
Today : $88.59 — upside -9%
🎯 on ARWR : no call matured yet · 📊 on Health : 64.8% · +20.2% (105 calls)
in progress (365j)
matures : Dec 9, 26
matures : Dec 9, 26
HC Wainwright & Co. ↗
Dec 2, 25
▲ Buy · 🎯$85
Price at call : $57.95 — upside +47%
Today : $88.59 — upside -4%
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
in progress (365j)
matures : Dec 2, 26
matures : Dec 2, 26
B of A Securities ↗
Dec 1, 25
▲ Buy · 🎯$62
Price at call : $57.95 — upside +7%
Today : $88.59 — upside -30%
🎯 on ARWR : no call matured yet · 📊 on Health : 64.8% · +20.2% (105 calls)
in progress (365j)
matures : Dec 1, 26
matures : Dec 1, 26
Chardan Capital
Dec 1, 25
▲ Buy · 🎯$60
Price at call : $56.25 — upside +7%
Today : $88.59 — upside -32%
🎯 on ARWR : 42% (19 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
in progress (365j)
matures : Dec 1, 26
matures : Dec 1, 26
Morgan Stanley ↗
Nov 26, 25
■ Equal-Weight neutral · not a buy · 🎯$48
Price at call : $52.7 — gap to target -9%
Today : $88.59 — gap to target -46%
🎯 on ARWR : no call matured yet · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Nov 26, 26
matures : Nov 26, 26
Goldman Sachs ↗
Nov 20, 25
■ Neutral neutral · not a buy · 🎯$48
Price at call : $38.09 — gap to target +26%
Today : $88.59 — gap to target -46%
🎯 on ARWR : no call matured yet · 📊 on Health : 57.9% · +13.8% (107 calls)
in progress (365j)
matures : Nov 20, 26
matures : Nov 20, 26
RBC Capital ↗
Nov 19, 25
▲ Outperform · 🎯$52
Price at call : $38.09 — upside +37%
Today : $88.59 — upside -41%
🎯 on ARWR : 100% (2 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
in progress (365j)
matures : Nov 19, 26
matures : Nov 19, 26
Chardan Capital
Nov 19, 25
▲ Buy · 🎯$60
Price at call : $38.97 — upside +54%
Today : $88.59 — upside -32%
🎯 on ARWR : 42% (19 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
in progress (365j)
matures : Nov 19, 26
matures : Nov 19, 26
Piper Sandler ↗
Nov 19, 25
▲ Overweight · 🎯$70
Price at call : $38.97 — upside +80%
Today : $88.59 — upside -21%
🎯 on ARWR : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Nov 19, 26
matures : Nov 19, 26
Morgan Stanley ↗
Nov 12, 25
■ Equal-Weight neutral · not a buy · 🎯$45
Price at call : $41.14 — gap to target +9%
Today : $88.59 — gap to target -49%
🎯 on ARWR : no call matured yet · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Nov 12, 26
matures : Nov 12, 26
HC Wainwright & Co. ↗
Oct 8, 25
▲ Buy · 🎯$80
Price at call : $36.94 — upside +117%
Today : $88.59 — upside -10%
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
in progress (365j)
matures : Oct 8, 26
matures : Oct 8, 26
HC Wainwright & Co. ↗
Sep 2, 25
▲ Buy · 🎯$80
Price at call : $27.8 — upside +188%
Today : $88.59 — upside -10%
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
in progress (365j)
matures : Sep 2, 26
matures : Sep 2, 26
Chardan Capital
Aug 11, 25
▲ Buy · 🎯$60
Price at call : $17.21 — upside +249%
Today : $88.59 — upside -32%
Expected +249% · Actual +419% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 42% (19 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
+418.5%
stock +419% · XLV +29%
matured Aug 11, 26
RBC Capital ↗
Aug 8, 25
▲ Outperform · 🎯$38
Price at call : $17.21 — upside +121%
Today : $88.59 — upside -57%
Expected +121% · Actual +413% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 100% (2 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
+413.3%
stock +413% · XLV +29%
matured Aug 8, 26
HC Wainwright & Co. ↗
May 20, 25
▲ Buy · 🎯$80
Price at call : $16.29 — upside +391%
Today : $88.59 — upside -10%
Expected +391% · Actual +374% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+373.5%
stock +374% · XLV +9%
matured May 20, 26
■ Neutral neutral · not a buy · 🎯$17
Price at call : $14.91 — gap to target +14%
Today : $88.59 — gap to target -81%
🎯 on ARWR : no call matured yet · 📊 on Health : 56% · +15.7% (125 calls)
in progress (365j)
matures : May 13, 26
matures : May 13, 26
Chardan Capital
May 13, 25
▲ Buy · 🎯$60
Price at call : $15.28 — upside +293%
Today : $88.59 — upside -32%
Expected +293% · Actual +410% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 42% (19 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
+409.7%
stock +410% · XLV +11%
matured May 13, 26
B. Riley Securities ↗
Feb 14, 25
▲ Buy · 🎯$38
Price at call : $20.44 — upside +86%
Today : $88.59 — upside -57%
Expected +86% · Actual +212% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 50% (10 calls matureds) · 📊 on Health : 47.8% · +20.1% (23 calls)
+211.6%
stock +212% · XLV +9%
matured Feb 14, 26
HC Wainwright & Co. ↗
Feb 12, 25
▲ Buy · 🎯$80
Price at call : $18.57 — upside +331%
Today : $88.59 — upside -10%
Expected +331% · Actual +236% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+235.9%
stock +236% · XLV +7%
matured Feb 12, 26
RBC Capital ↗
Feb 11, 25
▲ Outperform · 🎯$42
Price at call : $18.57 — upside +126%
Today : $88.59 — upside -53%
Expected +126% · Actual +236% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 100% (2 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
+235.9%
stock +236% · XLV +7%
matured Feb 11, 26
Chardan Capital
Feb 11, 25
▲ Buy · 🎯$60
Price at call : $18.89 — upside +218%
Today : $88.59 — upside -32%
Expected +218% · Actual +226% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 42% (19 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
+225.8%
stock +226% · XLV +7%
matured Feb 11, 26
HC Wainwright & Co. ↗
Jan 23, 25
▲ Buy · 🎯$80
Price at call : $21.53 — upside +272%
Today : $88.59 — upside -10%
Expected +272% · Actual +211% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+211.4%
stock +211% · XLV +9%
matured Jan 23, 26
HC Wainwright & Co. ↗
Jan 22, 25
▲ Buy · 🎯$80
Price at call : $19.71 — upside +306%
Today : $88.59 — upside -10%
Expected +306% · Actual +253% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+253.1%
stock +253% · XLV +11%
matured Jan 22, 26
HC Wainwright & Co. ↗
Dec 20, 24
▲ Buy · 🎯$80
Price at call : $19.75 — upside +305%
Today : $88.59 — upside -10%
Expected +305% · Actual +249% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+249.4%
stock +249% · XLV +12%
matured Dec 20, 25
Chardan Capital
Dec 12, 24
▲ Buy · 🎯$60
Price at call : $22.14 — upside +171%
Today : $88.59 — upside -32%
Expected +171% · Actual +217% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 42% (19 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
+216.6%
stock +217% · XLV +9%
matured Dec 12, 25
HC Wainwright & Co. ↗
Dec 3, 24
▲ Buy · 🎯$80
Price at call : $23.11 — upside +246%
Today : $88.59 — upside -10%
Expected +246% · Actual +180% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+179.8%
stock +180% · XLV +5%
matured Dec 3, 25
■ Market Perform neutral · not a buy · 🎯$24
Price at call : $26.03 — gap to target -8%
Today : $88.59 — gap to target -73%
🎯 on ARWR : no call matured yet · 📊 on Health : 50% · -5.0% (6 calls)
in progress (365j)
matures : Nov 29, 25
matures : Nov 29, 25
Chardan Capital
Nov 27, 24
▲ Buy · 🎯$60
Price at call : $26.15 — upside +129%
Today : $88.59 — upside -32%
Expected +129% · Actual +102% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 42% (19 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
+101.5%
stock +102% · XLV +7%
matured Nov 27, 25
HC Wainwright & Co. ↗
Nov 20, 24
▲ Buy · 🎯$60
Price at call : $18.28 — upside +228%
Today : $88.59 — upside -32%
Expected +228% · Actual +121% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+121.3%
stock +121% · XLV +7%
matured Nov 20, 25
HC Wainwright & Co. ↗
Oct 11, 24
▲ Buy · 🎯$60
Price at call : $19.36 — upside +210%
Today : $88.59 — upside -32%
Expected +210% · Actual +87% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+87.2%
stock +87% · XLV -8%
matured Oct 11, 25
Cantor Fitzgerald ↗
Sep 9, 24
▲ Overweight
Actual +35% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 63% (8 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
+34.6%
stock +35% · XLV -12%
matured Sep 9, 25
HC Wainwright & Co. ↗
Sep 5, 24
▲ Buy · 🎯$60
Price at call : $23.25 — upside +158%
Today : $88.59 — upside -32%
Expected +158% · Actual +25% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+25.1%
stock +25% · XLV -11%
matured Sep 5, 25
HC Wainwright & Co. ↗
Sep 3, 24
▲ Buy · 🎯$60
Price at call : $23.98 — upside +150%
Today : $88.59 — upside -32%
Expected +150% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+16.8%
stock +17% · XLV -12%
matured Sep 3, 25
B. Riley Securities ↗
Aug 12, 24
▲ Buy · 🎯$55
Price at call : $22.85 — upside +141%
Today : $88.59 — upside -38%
Expected +141% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on ARWR : 50% (10 calls matureds) · 📊 on Health : 47.8% · +20.1% (23 calls)
-12.5%
stock -13% · XLV -12%
matured Aug 12, 25
HC Wainwright & Co. ↗
Jul 23, 24
▲ Buy · 🎯$60
Price at call : $28.91 — upside +108%
Today : $88.59 — upside -32%
Expected +108% · Actual -44% · Reason (≥ +15%) : ✗ No
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
-43.8%
stock -44% · XLV -9%
matured Jul 23, 25
Chardan Capital
Jul 17, 24
▲ Buy · 🎯$60
Price at call : $27.64 — upside +117%
Today : $88.59 — upside -32%
Expected +117% · Actual -39% · Reason (≥ +15%) : ✗ No
🎯 on ARWR : 42% (19 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
-39.4%
stock -39% · XLV -10%
matured Jul 17, 25
HC Wainwright & Co. ↗
Jul 5, 24
▲ Buy · 🎯$60
Price at call : $25.57 — upside +135%
Today : $88.59 — upside -32%
Expected +135% · Actual -34% · Reason (≥ +15%) : ✗ No
🎯 on ARWR : 83% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
-34.1%
stock -34% · XLV -7%
matured Jul 5, 25
Chardan Capital
Jun 26, 24
▲ Buy · 🎯$60
Price at call : $26.26 — upside +128%
Today : $88.59 — upside -32%
Expected +128% · Actual -39% · Reason (≥ +15%) : ✗ No
🎯 on ARWR : 42% (19 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
-38.8%
stock -39% · XLV -8%
matured Jun 26, 25
Cantor Fitzgerald ↗
Jun 20, 24
▲ Overweight
Actual -39% · Reason (≥ +15%) : ✗ No
🎯 on ARWR : 63% (8 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
-39.2%
stock -39% · XLV -10%
matured Jun 20, 25
Chardan Capital
Jun 3, 24
▲ Buy · 🎯$60
Price at call : $25.29 — upside +137%
Today : $88.59 — upside -32%
Expected +137% · Actual -34% · Reason (≥ +15%) : ✗ No
🎯 on ARWR : 42% (19 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
-33.8%
stock -34% · XLV -8%
matured Jun 3, 25
Chardan Capital
May 10, 24
▲ Buy · 🎯$60
Price at call : $22.06 — upside +172%
Today : $88.59 — upside -32%
Expected +172% · Actual -37% · Reason (≥ +15%) : ✗ No
🎯 on ARWR : 42% (19 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
-36.7%
stock -37% · XLV -5%
matured May 10, 25
Chardan Capital
Aug 8, 23
▲ Buy · 🎯$60
Price at call : $29.01 — upside +107%
Today : $88.59 — upside -32%
Expected +107% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on ARWR : 42% (19 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
-10.9%
stock -11% · XLV +11%
matured Aug 7, 24
Cantor Fitzgerald ↗
Aug 8, 23
▲ Overweight · 🎯$47
Price at call : $29.01 — upside +62%
Today : $88.59 — upside -47%
Expected +62% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on ARWR : 63% (8 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
-10.9%
stock -11% · XLV +11%
matured Aug 7, 24
B. Riley Securities ↗
Jul 20, 23
▲ Buy · 🎯$55
Price at call : $36.08 — upside +52%
Today : $88.59 — upside -38%
Expected +52% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on ARWR : 50% (10 calls matureds) · 📊 on Health : 47.8% · +20.1% (23 calls)
-20.3%
stock -20% · XLV +9%
matured Jul 19, 24
Chardan Capital
Jun 2, 23
▲ Buy · 🎯$60
Price at call : $36.05 — upside +66%
Today : $88.59 — upside -32%
Expected +66% · Actual -32% · Reason (≥ +15%) : ✗ No
🎯 on ARWR : 42% (19 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
-31.7%
stock -32% · XLV +11%
matured Jun 1, 24
Chardan Capital
May 24, 23
▲ Buy · 🎯$60
Price at call : $35.57 — upside +69%
Today : $88.59 — upside -32%
Expected +69% · Actual -31% · Reason (≥ +15%) : ✗ No
🎯 on ARWR : 42% (19 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
-30.6%
stock -31% · XLV +12%
matured May 23, 24
Chardan Capital
Feb 10, 23
▲ Buy · 🎯$60
Price at call : $33.12 — upside +81%
Today : $88.59 — upside -32%
Expected +81% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on ARWR : 42% (19 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
-2.6%
stock -3% · XLV +9%
matured Feb 10, 24
B. Riley Securities ↗
Feb 8, 23
▲ Buy · 🎯$55
Price at call : $33.16 — upside +66%
Today : $88.59 — upside -38%
Expected +66% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on ARWR : 50% (10 calls matureds) · 📊 on Health : 47.8% · +20.1% (23 calls)
-1.8%
stock -2% · XLV +10%
matured Feb 8, 24
B. Riley Securities ↗
Nov 30, 22
▲ Buy · 🎯$59
Price at call : $32.02 — upside +84%
Today : $88.59 — upside -33%
Expected +84% · Actual -28% · Reason (≥ +15%) : ✗ No
🎯 on ARWR : 50% (10 calls matureds) · 📊 on Health : 47.8% · +20.1% (23 calls)
-27.6%
stock -28% · XLV -5%
matured Nov 30, 23
Chardan Capital
May 11, 22
▲ Buy · 🎯$80
Price at call : $30.31 — upside +164%
Today : $88.59 — upside -10%
Expected +164% · Actual +30% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 42% (19 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
+29.7%
stock +30% · XLV +4%
matured May 11, 23
Chardan Capital
Aug 6, 21
▲ Buy · 🎯$94
Price at call : $62.78 — upside +50%
Today : $88.59 — upside +6%
Expected +50% · Actual -25% · Reason (≥ +15%) : ✗ No
🎯 on ARWR : 42% (19 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
-25.1%
stock -25% · XLV -1%
matured Aug 6, 22
B. Riley Securities ↗
Feb 8, 21
▲ Buy · 🎯$106
Price at call : $89.8 — upside +18%
Today : $88.59 — upside +20%
Expected +18% · Actual -39% · Reason (≥ +15%) : ✗ No
🎯 on ARWR : 50% (10 calls matureds) · 📊 on Health : 47.8% · +20.1% (23 calls)
-39.1%
stock -39% · XLV +16%
matured Feb 8, 22
Chardan Capital
Feb 5, 21
▲ Buy · 🎯$97
Price at call : $90.47 — upside +7%
Today : $88.59 — upside +9%
Expected +7% · Actual -42% · Reason (≥ +15%) : ✗ No
🎯 on ARWR : 42% (19 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
-42.4%
stock -42% · XLV +14%
matured Feb 5, 22
Cantor Fitzgerald ↗
May 8, 20
▲ Overweight · 🎯$58
Price at call : $34.14 — upside +70%
Today : $88.59 — upside -35%
Expected +70% · Actual +94% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 63% (8 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
+93.6%
stock +94% · XLV +25%
matured May 8, 21
Cantor Fitzgerald ↗
Apr 15, 20
▲ Overweight · 🎯$60
Price at call : $35.33 — upside +70%
Today : $88.59 — upside -32%
Expected +70% · Actual +92% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 63% (8 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
+92.4%
stock +92% · XLV +25%
matured Apr 15, 21
B. Riley Securities ↗
Mar 13, 20
▲ Buy · 🎯$57
Price at call : $26.32 — upside +117%
Today : $88.59 — upside -36%
Expected +117% · Actual +173% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 50% (10 calls matureds) · 📊 on Health : 47.8% · +20.1% (23 calls)
+173.0%
stock +173% · XLV +27%
matured Mar 13, 21
B. Riley Securities ↗
Nov 13, 19
▲ Buy · 🎯$59
Price at call : $48.51 — upside +22%
Today : $88.59 — upside -33%
Expected +22% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 50% (10 calls matureds) · 📊 on Health : 47.8% · +20.1% (23 calls)
+42.7%
stock +43% · XLV +16%
matured Nov 12, 20
Chardan Capital
Oct 22, 19
▲ Buy · 🎯$45
Price at call : $38.97 — upside +15%
Today : $88.59 — upside -49%
Expected +15% · Actual +46% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 42% (19 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
+45.5%
stock +46% · XLV +15%
matured Oct 21, 20
B. Riley Securities ↗
Aug 19, 19
▲ Buy · 🎯$46
Price at call : $33.72 — upside +36%
Today : $88.59 — upside -48%
Expected +36% · Actual +32% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 50% (10 calls matureds) · 📊 on Health : 47.8% · +20.1% (23 calls)
+32.1%
stock +32% · XLV +17%
matured Aug 18, 20
Cantor Fitzgerald ↗
Dec 17, 18
▲ Overweight · 🎯$165
Price at call : $13.96 — upside +1082%
Today : $88.59 — upside +86%
Expected +1082% · Actual +372% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 63% (8 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
+371.7%
stock +372% · XLV +17%
matured Dec 17, 19
Chardan Capital
Sep 6, 18
▲ Buy · 🎯$24.5
Price at call : $19.74 — upside +24%
Today : $88.59 — upside -72%
Expected +24% · Actual +45% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 42% (19 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
+45.4%
stock +45% · XLV -2%
matured Sep 6, 19
B. Riley Securities ↗
Sep 6, 18
▲ Buy
Actual +63% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 50% (10 calls matureds) · 📊 on Health : 47.8% · +20.1% (23 calls)
+62.5%
stock +63% · XLV -1%
matured Sep 6, 19
Cantor Fitzgerald ↗
May 9, 18
▲ Overweight
Actual +116% · Reason (≥ +15%) : ✓ Yes
🎯 on ARWR : 63% (8 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
+116.1%
stock +116% · XLV +10%
matured May 9, 19
Chardan Capital
Nov 30, 16
■ Neutral neutral · not a buy
🎯 on ARWR : 42% (19 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
in progress (365j)
matures : Nov 30, 17
matures : Nov 30, 17
Cantor Fitzgerald ↗
Aug 18, 16
▲ Buy
Actual -70% · Reason (≥ +15%) : ✗ No
🎯 on ARWR : 63% (8 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
-70.0%
stock -70% · XLV +5%
matured Aug 18, 17
Chardan Capital
May 19, 16
▲ Buy · 🎯$12
Price at call : $5.01 — upside +140%
Today : $88.59 — upside -86%
Expected +140% · Actual -67% · Reason (≥ +15%) : ✗ No
🎯 on ARWR : 42% (19 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
-67.3%
stock -67% · XLV +9%
matured May 19, 17
Frequently asked questions
Should I buy Arrowhead Pharmaceuticals stock?
This isn't buy advice. For Arrowhead Pharmaceuticals, the analyst consensus is "Buy", with an average price target of $107 (+20% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 75% of the time (4 calls tracked on Arrowhead Pharmaceuticals). We show the numbers — you decide.
Is it too late to buy Arrowhead Pharmaceuticals? How high can it go?
The most bullish analyst target on Arrowhead Pharmaceuticals is $126 (+42% above today's price); the average is $107. That's the upside they see. Check how reliable those analysts have actually been on Arrowhead Pharmaceuticals on our site before trusting it.
Is Arrowhead Pharmaceuticals still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 10 analysts have a real record on Arrowhead Pharmaceuticals, the best hitting 75% over 4 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Arrowhead Pharmaceuticals? The case for and against
The arguments for and against, one by one, from the numbers: why invest in ARWR (and why hesitate).
What has Arrowhead Pharmaceuticals's past performance been?
Historical returns and a "how much if I had invested" calculator: ARWR performance & returns.
What is the best month to buy ARWR?
The 12 months ranked by the stock's past returns: best & worst month to buy ARWR.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX